middle.news
Neurizon Locks in Five-Year Supply Deal with Elanco to Boost NUZ-001 Commercialisation
9:07am on Wednesday 17th of June, 2026 AEST
•
Biotechnology
Read Story
Neurizon Locks in Five-Year Supply Deal with Elanco to Boost NUZ-001 Commercialisation
9:07am on Wednesday 17th of June, 2026 AEST
Key Points
Five-year GMP supply agreement with Elanco for monepantel
Strengthens manufacturing and regulatory infrastructure
Supports operational scalability and capital efficiency
Enhances NUZ-001’s attractiveness for pharma partnerships
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Neurizon Therapeutics (ASX:NUZ)
OPEN ARTICLE